Neogen Corporation (NEOG)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $2.45B
Last updated: Nov 17, 2026 at 11:06 AM ET
Neogen Corporation (NEOG) P/E Ratio & Valuation History
Neogen (NEOG) trades at 32.0x trailing earnings and 2.7x sales. Its P/E of 32.0x is below its 5-year median of 33.8x. Its forward P/E is 16.0x. The median P/E across 8 similar companies is 22.6x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 100.0% higher over the next year. Its free cash flow yield is 2.1%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 32.0x |
| Forward P/E | 16.0x |
| Price to sales | 2.7x |
| Price to book | 1.1x |
| EV/EBITDA | 26.2x |
| Price to FCF | 47.7x |
| EV/FCF | 59.8x |
| PEG | 0.7 |
| FCF yield | 2.1% |
Historical Medians
Against its 10-year medians, its P/E is 37.5% below 51.2x, its P/S is 62.5% below 7.2x and its P/B is 76.1% below 4.6x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 32.0x | 33.8x | 51.2x |
| P/S | 2.7x | 3.5x | 7.2x |
| P/B | 1.1x | 1.2x | 4.6x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 24.1x in 2025 to 87.5x in 2017. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $6.99 | 24.1x | 1.7x | 0.7x |
| 2024 | $12.14 | 30.4x | 2.9x | 1.0x |
| 2023 | $20.11 | 41.9x | 4.8x | 1.4x |
| 2022 | $15.23 | 26.7x | 3.2x | 1.1x |
| 2021 | $45.41 | 84.1x | 9.7x | 5.6x |
| 2020 | $39.65 | 68.4x | 9.7x | 5.4x |
| 2019 | $32.63 | 56.3x | 8.2x | 5.0x |
| 2018 | $28.50 | 47.5x | 7.3x | 4.9x |
| 2017 | $41.11 | 87.5x | 9.6x | 8.1x |
| 2016 | $33.00 | 84.6x | 7.8x | 5.8x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About NEOG
What is NEOG's forward P/E ratio?
Neogen has a forward P/E ratio of 16.0x.
Is NEOG stock overvalued?
GNG's valuation label for NEOG is Undervalued. Its P/E of 32.0x compares with a median of 22.6x across 8 similar companies.
What is NEOG's price to sales ratio?
Neogen has a price to sales ratio of 2.7x.
What is Neogen's average P/E ratio over 5 years?
Neogen's median P/E over the last 5 years is 33.8x, from 60 month-end values through Oct 2026.
What is NEOG's PEG ratio?
Neogen has a PEG ratio of 0.7.
NEOG pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts